New Oversight Layers Needed as AI Evolves at Pace
Artificial intelligence is advancing faster than existing governance structures, prompting calls for stronger oversight across clinical and operational workflows. Dr. Ryan Sadeghian, CMIO at the University of Toledo, warns that without multi‑layered frameworks, AI tools could jeopardize patient safety and data integrity. HIMSS is responding by hosting a one‑day AI Executive Leadership Summit on June 24, 2026, followed by a three‑day AI in Healthcare Forum. The events aim to shape industry standards and share best practices for safe AI deployment.
Judge Dismisses BCBS Texas’ Surprise Billing Lawsuit Against HaloMD
Federal Judge Robert W. Schroeder III dismissed Blue Cross Blue Shield of Texas’s lawsuit against billing intermediary HaloMD, ruling that courts lack authority to review arbitration decisions under the No Surprises Act. The ruling marks the fourth federal dismissal in...
Augurex Named ADLM 2026 Disruptive Technology Award Finalist
Augurex Life Sciences Corp. has been named a finalist for the ADLM 2026 Disruptive Technology Award for its SPINEstat® Anti‑14‑3‑eta Multiplex test, a first‑in‑class diagnostic for axial spondyloarthritis (axSpA). The company will present the technology at the ADLM conference in...
Biohub Open-Source AI Model Targets Protein Design for Drug Discovery
Biohub, part of the Chan Zuckerberg Initiative, launched an open‑source AI system that models protein biology at evolutionary scale to aid early‑stage drug discovery. The platform, described as a “world model,” was used to design protein binders targeting cancer and...
Is Immune Priming the Missing Piece in Oncology? Oncolytics Biotech Thinks So
Oncolytics Biotech is positioning its oncolytic virus pelareorep as an "immune‑priming backbone" to boost the efficacy of existing cancer therapies. Recent combination trials have shown striking survival gains—median overall survival of 27 months in metastatic colorectal cancer and a two‑year...
FDA Drug Competition Action Plan | Improving the Efficiency of the Generic Drug Development, Review, and Approval Process
The FDA’s Drug Competition Action Plan (DCAP) is rolling out a series of new and revised guidances aimed at streamlining generic drug development, review, and approval. Recent releases include May 2026 bioequivalence guidance with pharmacokinetic endpoints and October 2024 product‑specific guidances aligned...
Md. County Reverses Course, Approves Whole Blood Program for Trauma Patients
Somerset County, Maryland, voted unanimously to launch a whole‑blood program for trauma patients, reversing a month‑old opposition. The initiative will be funded by a state grant of $58,338 per year for five years, allowing ambulances to carry unseparated blood for...
The Next Useful Layer in Radiology AI Is Patient Comprehension
Radiology AI is moving beyond autonomous diagnosis toward a patient‑facing translation layer that converts complex imaging reports into plain language. While the 21st Century Cures Act has accelerated instant result access, most patients lack the health literacy to interpret the...
A $4 Tongue Swab Test Detects Tuberculosis Within 30 Minutes
Researchers have unveiled MiniDock MTB, a portable $400 device that uses $4 tongue‑swab tests to detect tuberculosis in 12‑25 minutes. The World Health Organization endorsed the test in March, marking the first official approval for a community‑based TB assay requiring minimal...
Philips Partners with Disney to Scale Ambient Experience for MRI Globally
Philips and The Walt Disney Company have launched a global partnership to embed Disney characters and storylines into Philips’ Ambient Experience platform for MRI suites in 87 countries. A multi‑center European study found that Disney‑themed audio‑visual environments cut pediatric stress...
Traws Pharma Announces New Antiviral Program
Traws Pharma announced a new antiviral development program aimed at emerging RNA viruses and other high‑risk pathogens. The initiative earmarks roughly $200 million over the next five years to fund pre‑clinical research, platform technology, and early‑stage clinical trials. The company is...
Signs of Post-Viral Depression Found in Our Immune System for the First Time
Researchers at biotech firm Tuning Fork analyzed saliva IgA antibodies from pandemic‑era volunteers and identified distinct immune signatures in individuals experiencing post‑COVID depression. The findings suggest that a subset of post‑viral depression may have measurable biological markers, moving beyond purely...
Use of Ultra-Rapid Insulin Plus MiniMed 780G Raises Time in Range
A single‑arm trial of 211 participants with type 1 diabetes showed that pairing Eli Lilly’s ultra‑rapid insulin lispro‑aabc (Lyumjev) with Medtronic’s MiniMed 780G hybrid closed‑loop system significantly boosted time‑in‑range. Children achieved a mean TIR of 68.6% (up from 51.2%) and adults reached...
Statistical Approaches to Establishing Bioequivalence
The FDA has released a final guidance titled “Statistical Approaches to Establishing Bioequivalence,” superseding the 2001 version and formalizing the December 2022 draft. The document outlines recommended statistical methods for bioequivalence (BE) assessments across INDs, NDAs, ANDAs, and related amendments. It...
Healthcare Cost Inflation Is Back in the Headlines
Blockades in the Strait of Hormuz are inflating global healthcare costs as trade disruptions raise fuel, shipping and manufacturing expenses. The resulting supply bottlenecks have already driven notable price spikes for prescription drugs in markets such as Brazil, Sweden and...
Vertex’s Journavx Made History, but Left a Void in the Pain Space
Vertex Pharmaceuticals secured FDA approval for Journavx, the first novel non‑opioid pain drug in decades, amid the ongoing opioid crisis and Purdue Pharma’s recent multi‑billion‑dollar settlement. The medication targets the NaV1.8 sodium channel and quickly reached one million prescriptions, but...
Lung Cancer Risks Increase with Cannabis Use Disorder
A new retrospective cohort study of nearly 150,000 patients with cannabis‑use disorder found a 3.9‑fold increased risk of lung cancer compared with matched controls. The elevated risk was consistent across adenocarcinoma, squamous‑cell and small‑cell subtypes. Prior meta‑analyses showed no clear...
Ironwood Pharmaceuticals Reports the US FDA Approval of Linzess to Treat Pediatric Patients (≥2yrs.) With Functional Constipation
U.S. FDA has approved an expanded label for Ironwood Pharmaceuticals’ Linzess (linaclotide) for children aged two years and older with functional constipation. The decision follows a 12‑week Phase III trial in 2‑ to 5‑year‑old patients, where the 72 µg dose significantly increased...
Message by the WHO Director-General to the People of the Democratic Republic of the Congo
World Health Organization Director‑General Tedros addressed the people of Ituri, DRC, announcing that the province is bearing the brunt of the country’s 17th Ebola outbreak, with over 90% of cases there. The outbreak is caused by the Bundibugyo strain, for...
3D-Printed Lymph Nodes Could Widen Access to CAR T-Cell Therapy
Researchers have shown that 3D‑printed lymph‑node scaffolds can grow CAR‑T cells more quickly and at a lower cost. The bioprinting method compresses the manufacturing timeline from several weeks to just a few days, potentially cutting expenses by up to 70...
US Abortion Restrictions Are Hindering Access to Miscarriage Care, Study Finds
A JAMA study of 123,598 privately insured patients shows that states enforcing post‑Dobbs abortion bans have shifted miscarriage care away from medication toward expectant management, with a 2.8‑percentage‑point rise in wait‑and‑see approaches and a 2.2‑point drop in medication use. In...
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
Conavi Medical Corp. secured FDA 510(k) clearance for its next‑generation Novasight™ Hybrid intravascular imaging system, integrating IVUS and OCT into a single workflow. The company also earned the 2026 MedTech Breakthrough and TAG Innovation awards, underscoring the technology’s clinical promise....
Bihar Govt Approves Cashless Healthcare Scheme for Employees and Pensioners
The Bihar government approved a cashless health scheme that will let state employees, pensioners, their families and certain officials receive indoor medical treatment without paying up front. Beneficiaries will be issued health cards, and hospitals will be reimbursed directly through...
Dr Reddy’s to Ring NYSE Closing Bell to Mark 25 Years of Listing
Dr Reddy’s Laboratories will ring the New York Stock Exchange closing bell on May 29, 2026 to celebrate 25 years since its historic 2001 NYSE debut—the first Asian pharmaceutical firm outside Japan to list on the exchange. Chairman Satish Reddy highlighted the milestone as proof...
Screening Guidelines Omit Many Patients at High Risk for Cancer
Researchers analyzed data from 446,795 UK Biobank participants aged 40‑70 and built risk models that incorporate 118 lifestyle and environmental variables for 21 common cancers. Aligning modifiable risk factors to ideal levels could lower overall cancer risk by about 9...
Ill. EMS Moves Into Firehouse to Reduce Response Times
Greene County Ambulance Service will station an advanced‑life‑support unit inside the Roodhouse Fire Protection District firehouse within two weeks. The move places two EMS personnel closer to the northern part of the county, where roughly 75% of ambulance runs originate....
Book Review: Unravelling MAiD in Canada: Euthanasia and Assisted Suicide as Medical Care
The newly released volume *Unravelling MAiD in Canada* provides a comprehensive legal and ethical analysis of Canada’s medical assistance in dying (MAiD) regime. Edited by physician Ramona Coelho, psychiatrist K. Sonu Gaind, and health‑law scholar Trudo Lemmons, the 552‑page work...
Perceptic Raises £9m to Boost AI Drug Discovery
Perceptic announced a $12 million seed round, led by Accel, Air Street Capital and Elder Gull, to develop a unified AI platform for the entire drug lifecycle. The system aims to integrate asset scouting, scientific evaluation and clinical data into a...
These Ebola Researchers Are Stuck in US Due to Trump’s Funding Cuts
The Trump administration terminated the NIH‑funded Centers for Research in Emerging Infectious Diseases (CREID) network, cutting roughly $82 million in funding after labeling the work “unsafe for Americans.” The network, which operated ten global sites and had built diagnostic capacity for...
Agentic AI Meets Specialty Care: How an Orthopedic Practice Is Simplifying Post-Surgical Care
Michigan Orthopedic Center, an 11‑surgeon private practice in Lansing, partnered with AI vendor IntelePeer to launch a voice‑based Clinical Assessment Agent. The tool conducts post‑surgical patient interviews, captures pain, wound and medication data, and automatically generates clinical summaries for the...
Genetic Scores Are Booming. But Will Anti-Discrimination Laws Cover Your DNA?
Polygenic risk scoring, a fast‑growing branch of personalized medicine, uses thousands of DNA variants to estimate an individual’s chance of developing diseases such as heart disease, diabetes, or cancer. While the Genetic Information Nondiscrimination Act (GINA) prevents employers from firing...
Listen to the Latest ‘KFF Health News Minute’
Suicide‑prevention researchers highlighted that improving Americans’ financial health could significantly reduce suicide rates, urging policymakers to address debt and income insecurity. At the same time, the Trump administration announced plans to ease artificial‑intelligence safeguards in the healthcare sector, aiming to...
In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
Shasta County, a conservative region of northern California, identified its first measles case in late January and launched an aggressive containment effort. Public health officials traced nine cases, contacted more than 600 potential exposures across venues like Costco and a...
Official Statistics: Mefloquine (Larium) Prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2026
The Ministry of Defence released an official statistical bulletin on 28 May 2026 detailing mefloquine (Lariam) prescribing for UK armed forces from 12 September 2016 through 31 March 2026. The report follows a policy shift introduced in September 2016 that tightened prescribing criteria for the antimalarial drug....
STAT+: Trump’s Drug-Pricing Deals Set to Be Tested by New Product Launches
President Trump’s most‑favored‑nation (MFN) agreements with 17 drugmakers require new U.S. launches to be priced at net levels comparable to other wealthy nations. The policy, whose terms remain secret, is slated for its first public test as three drugs—AstraZeneca’s hypertension...
A Nigerian Teen Is Turning Agricultural Waste Into Biodegradable Sanitary Pads
Nigerian teenager Raheema Auwal‑Panti founded PantiPads to turn agricultural waste into biodegradable sanitary pads, addressing both menstrual health access and plastic pollution. The pads use cassava peels, banana leaves and corn husks, offering a compostable alternative to conventional pads that...
Sanofi’s Venglustat Secures the US FDA Priority Review for Type 3 Gaucher Disease
Sanofi’s oral glucosylceramide synthase inhibitor venglustat has received FDA acceptance of its New Drug Application and a priority‑review designation for treating the neurological manifestations of type 3 Gaucher disease (GD3). The decision follows the phase‑III LEAP2MONO trial, which enrolled 43 patients...
Researchers Block Key Protein that Helps Parkinson’s Spread Through the Brain
Researchers at the University of Pennsylvania have pinpointed the brain immune protein GPNMB as a catalyst for the spread of alpha‑synuclein in Parkinson’s disease. In pre‑clinical experiments, monoclonal antibodies that block GPNMB prevented the protein’s propagation between neurons. Analysis of...
AbbVie Reports the US FDA Approval for Decnupaz to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
AbbVie’s Decnupaz (pivekimab sunirine‑pvzy) received U.S. FDA approval for treating adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra‑rare aggressive blood cancer. The decision was based on the global Phase I/II CADENZA trial that enrolled 84 CD123‑positive hematologic malignancy...
Interventional Radiologist Helps Chicago Children’s Hospital Achieve a World’s First
Physicians at Lurie Children’s Hospital have pioneered a world‑first technique that freezes the intercostal nerve at the rib‑harvesting site during microtia reconstruction. The 20‑minute, ultrasound‑guided cryoablation eliminates months of postoperative pain, allowing children to leave the hospital as early as...
At-Home Care Devices May Make Pediatric Emergencies Easier To Deal With
A Los Angeles children’s hospital launched an at‑home asthma monitoring program using a coin‑sized wearable smart stethoscope that streams lung sounds to physicians. The device enables continuous, remote tracking of breathing metrics, allowing clinicians to triage and intervene before severe...
Increased Funding Is Making At-Home Hospital Care A Reality
The Centers for Medicare & Medicaid Services launched the Acute Hospital Care at Home (AHCAH) initiative in November 2020, and Congress has now extended the program through September 2030. Early research shows that hospital‑at‑home episodes reduce 30‑day Medicare spending and lower mortality...
How Bayesian Health’s Sepsis AI Tool Is Decreasing Alerts & Saving Lives
Bayesian Health became the first company to obtain FDA clearance for a continuous AI‑driven sepsis monitoring system. The tool, validated across diverse hospitals, shows double the sensitivity of prior methods and cuts time to antibiotics in half when clinicians act...
Methodological Considerations for Evaluating Policy Impacts on Transgender and Non-Binary Youth Suicidality
The authors of a new Nature Human Behaviour paper critique a recent study that used difference‑in‑differences analysis to claim anti‑transgender legislation raises suicide attempts among transgender and non‑binary youth. They point out that post‑treatment data are heavily concentrated in a...
Autoantibodies in Long COVID: A Mechanistic Foothold in a Heterogeneous Disease
Two independent studies published in *Cell* and *Cell Reports Medicine* provide the first direct evidence that autoantibodies can drive core long COVID symptoms such as fatigue, pain, and cognitive impairment. Researchers isolated IgG from affected patients and transferred it to...
Sono-Tek Corp (SOTK) Q4 2026 Earnings Call Transcript
Sono‑Tek Corp reported Q2 FY2026 revenue of $5.16 million, a modest sequential increase and the sixth straight quarter above $5 million. The medical device segment surged 150% year‑over‑year to $1 million, while U.S./Canada sales slipped 22% but were more than offset by 153%...
Gene Therapies to Fix Failing Hearts Gain Steam After Years in the Doldrums
Gene‑therapy researchers have launched the first human trial aimed at regenerating heart muscle by silencing the SAV1 gene, a brake on cardiomyocyte division. Pre‑clinical work in pigs showed a 14% boost in ejection fraction, prompting U.S. regulators to green‑light the...
Australian Government Launches First National Perimenopause Awareness Campaign via Ogilvy
The Australian Government has launched its first national perimenopause awareness campaign, created by Ogilvy. The multi‑channel effort—spanning TV, digital, social, audio and out‑of‑home—targets women aged 35‑55 while also reaching younger women, health professionals and support networks. A dedicated website (health.gov.au/perimenopause)...
Veradigm CEO Sees Improving Traction in Revenue-Cycle Cross-Selling
Veradigm Inc. filed its delayed 2023 and 2024 annual reports, moving closer to SEC compliance after a years‑long audit remediation. Revenue for 2024 slipped to $594 million, roughly flat with 2022, while cumulative net losses from 2022‑2024 topped $320 million. The company...
Exploring Length of Stay in Native and Periprosthetic Hip Fractures in a Newly Established Ortho-Geriatric Co-Management Service: Male Sex and...
A new orthogeriatric co‑management program at a Northeastern academic hospital evaluated length of stay (LOS) for 328 admissions involving native and periprosthetic hip fractures. The analysis found no statistically significant LOS difference between fracture types, with median stays of six...